Shenzhen Weinisi Biotechnology Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhen Weinisi Biotechnology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VENYSIS. The owner is based in Shenzhen.

512-E056, Rongchao Economic and Trade

Centre, Lotus Street, Futian District

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VENYSIS
VENYSIS
Registered 2023

Trademark Classifications

Shenzhen Weinisi Biotechnology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Shenzhen Weinisi Biotechnology Co., Ltd have?

Shenzhen Weinisi Biotechnology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Weinisi Biotechnology Co., Ltd file in?

Shenzhen Weinisi Biotechnology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Shenzhen Weinisi Biotechnology Co., Ltd's most well-known trademarks?

Shenzhen Weinisi Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as VENYSIS. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Weinisi Biotechnology Co., Ltd's trademark registration success rate?

Shenzhen Weinisi Biotechnology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.